IL6 and neoplasm: Elevated IL-6 levels have been associated with larger tumor size, advanced tumor stage, metastasis, poor prognosis, and increased recurrence risk in esophageal cancer, multiple myeloma, and renal cell carcinoma, among others [7,11,14].